Botanical species · safety record

Senna insularis

The EFSA Compendium of Botanicals holds 3 constituent measurements and 1 adverse-effect record for Senna insularis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Senna insularis (Britton & Rose) H.S.Irwin & Ba

3Constituent measurements
1Safety records
3Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Alkaloids1
  • Chaksine1
  • Saponins1

Plant parts

  • Seed4

Preparations

  • Solvent extraction4

Effect types

  • Reproductive1

Target tissues

  • Uterus1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsSeedSolvent extractionPhytochemical screeningNo resolvable identifier
ChaksineSeedSolvent extractionTraditional analytical techniques (wet chemical tests)No resolvable identifier
SaponinsSeedSolvent extractionPhytochemical screeningNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
ReproductiveUterusSeedSolvent extractionRat (as animal)Reproduction toxicityResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Pandya, H., Kachwala, Y., Sawant, L., Pandita, N. Pharmacognostical screening of seeds of Cassia absus. Pharmacognosy Journal, 2010, vol. 2, no. 11, p. 419-426.
  2. Siddiqui, Salimuzzaman., Ahmed, Zafaruddhin. Alkaloids from seeds of Cassia absus, Linn. Proceedings - Indian Academy of Sciences, Section A, 1935, p. 421-425.
  3. Hamedi, A., Khoshnoud, M.J., Tanideh, N., Abbasi, F., Fereidoonnezhad, M., Mehrabani, D. Reproductive Toxicity of Cassia Absus Seeds in Female Rats: Possible Progesteronic Properties of Chaksine and b-Sitosterol. Pharmaceutical Chemistry Journal, 2015. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue